Elequin Capital’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Elequin Capital’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,500	Closed	-$25K	–	858
2022 Q3	$25K	Buy	+2,500	New	+$25.2K	0.01%	137

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Elequin Capital's ARCK Position: Q4 2022 in Review

Elequin Capital sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 2,500 shares — an estimated $25K sold.

Elequin Capital first reported a position in ARCK in Q3 2022 and held it in 1 quarter. The position peaked at $25K in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Elequin Capital reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Elequin Capital sold 2,500 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $25K.
Elequin Capital first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q3 2022 and held it in 1 quarter.
Elequin Capital's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $25K in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.